CRISPR

Tiny germs have a way to stay safe.

They keep a list of bad germs. This list helps them fight. It works like a shield for the cell.

When a bad germ attacks, the cell takes a piece of it. The cell adds this piece to its own list. This helps the cell find the bad germ later.

Special tiny tools then use the list. They find the bad germ and cut it up. This stops the bad germ from making the cell sick.

People can use these tools too. They can use them to change parts of a living thing. This helps scientists study how life works. It can even help treat some sicknesses.

Tiny germs like bacteria have a clever way to stay safe.

They use a system called CRISPR to fight off viruses. CRISPR is a set of DNA sequences found in many microbes. These sequences act like a memory of past attacks.

When a virus attacks, the cell takes a small piece of the virus DNA. It adds this piece to its own list of repeats. This list helps the cell recognize that same virus later.

To fight, the cell uses a protein called Cas9. Cas9 is an enzyme, which is a tool that makes changes happen. The CRISPR list acts as a guide for Cas9. The guide leads Cas9 to the matching virus DNA. Once there, Cas9 cuts the DNA to stop the virus.

Scientists found a way to use this tool in labs. They can use Cas9 to edit genes in living things. This can help with research or treating diseases. Emmanuelle Charpentier and Jennifer Doudna won a Nobel Prize for this work. They helped make the tool simple to use in 2020.

CRISPR is a special system found in tiny living things like bacteria and archaea.

It acts like a memory for these microbes. It helps them remember viruses that tried to attack them before. This system is a type of adaptive immunity. This means the living thing can learn to defend itself against specific threats. About half of all sequenced bacteria have these sequences. Nearly 90% of sequenced archaea use them too. This makes CRISPR a very common way for small life to stay safe.

The way it works is like a search-and-cut mission. First, the cell takes a small piece of DNA from a virus. It adds this piece into its own DNA list. These pieces are called spacers. When a virus attacks again, the cell uses a protein called Cas9.

The spacers act like a guide for the Cas9 enzyme. Cas9 uses the guide to find the matching virus DNA. Once it finds the target, Cas9 cuts the DNA strands. This stops the virus from working inside the cell.

Many scientists helped discover how this system works over many years. In 1987, Ishino and his team first described these repeating sequences in E. coli. Later, a scientist named Mojica studied how these repeats worked in archaea. He helped name the system CRISPR in 2001. Other researchers found that these sequences were actually pieces of virus DNA. In 2005, Barrangou showed that bacteria use these pieces to resist viruses. These discoveries changed how we understand tiny life.

In 2012, Emmanuelle Charpentier and Jennifer Doudna made a huge breakthrough. They showed how to make the system much simpler to use. They fused two parts of the guide into one single-guide RNA. This allowed Cas9 to target specific DNA more easily. Because of this work, they won the Nobel Prize in Chemistry in 2020. Other scientists also found different tools like Cas12a and Cas13. Cas12a makes different types of cuts than Cas9. Cas13 is unique because it targets RNA instead of DNA.

Today, scientists use CRISPR-Cas9 as a powerful tool for gene editing.

This means they can change DNA in living organisms. They use it for basic biological research. It also helps them create new biotechnological products. Some scientists even use it to try to treat diseases. In 2013, researchers applied this tool to human cell cultures. It is a way to rewrite the instructions of life. This technology connects the tiny world of bacteria to big medical goals.

CRISPR is a specialized family of DNA sequences found in prokaryotic organisms. These organisms include bacteria and archaea.

The acronym stands for Clustered Regularly Interspaced Short Palindromic Repeats. This system functions as a form of heritable, acquired immunity. It allows microbes to detect and destroy DNA from similar viruses during future infections. This mechanism is incredibly common in the microbial world. Approximately 50% of sequenced bacterial genomes contain CRISPR. Nearly 90% of sequenced archaea also possess these sequences.

The mechanism functions through a sequence of precise biological steps. First, a prokaryote survives an infection by a bacteriophage, which is a virus that attacks bacteria. The organism incorporates a DNA fragment from that virus into its own genome. These captured fragments are called spacers. These spacers are placed between short, repeated DNA sequences.

When the cell encounters the same virus again, it uses these spacers to recognize the invader. The cell produces RNA molecules from these spacer sequences. These RNA molecules act as guides for specialized enzymes. These enzymes then seek out and cut the matching viral DNA to stop the infection.

Scientists categorize these systems into two main classes based on their protein structures. Class 1 systems utilize a complex made of multiple Cas proteins to degrade foreign nucleic acids. These are divided into types I, III, and IV. Class 2 systems are different because they use a single large Cas protein to perform the task. Class 2 is further divided into types II, V, and VI. Within these types, there are 33 different subtypes. Each subtype is often identified by a unique "signature gene." Most systems include proteins from the "cas core," which includes the Cas1 through Cas9 protein families.

The history of CRISPR is a long journey of independent discoveries. In 1987, Ishino and colleagues first described these unusual repeating sequences in Escherichia coli. They noticed the sequences were clustered rather than being arranged consecutively. In 1993, van Solingen identified diverse sequences between repeats in M. tuberculosis. Later, Francisco Mojica studied these repeats in archaea. He identified these interrupted repeats in 20 different species of microbes by the year 2000. Mojica and Jansen proposed the name CRISPR in 2001. In 2005, Barrangou provided evidence that bacteria gain phage resistance by adding new spacer sequences.

A major technological breakthrough occurred in 2012. Researchers Emmanuelle Charpentier and Jennifer Doudna discovered how to simplify the system. They fused two separate RNA molecules, crRNA and tracrRNA, into a single-guide RNA. This allowed the Cas9 enzyme to target specific DNA sequences much more easily. This discovery was so significant that it earned them the Nobel Prize in Chemistry in 2020. This tool turned a natural defense mechanism into a precise instrument for genome editing. It allowed scientists to target and cut specific strands of DNA with high accuracy.

Different types of Cas proteins offer unique capabilities for researchers. Cas9 is a widely used enzyme that produces blunt ends when it cuts DNA. In contrast, the Cas12a enzyme, characterized in 2015, generates staggered cuts. Cas12a also relies on a "T-rich" protospacer adjacent motif, or PAM, to find its target. This provides different targeting options than the "G-rich" PAM used by Cas9. Another enzyme, Cas13, is unique because it targets single-stranded RNA instead of DNA.

Because Cas13 can cleave RNA molecules, it is being used to develop new diagnostic technologies.

Today, CRISPR-Cas9 technology has massive implications for science and medicine. It is used for basic biological research and the development of biotechnological products. In 2013, researchers successfully applied CRISPR-Cas9 to edit human cell cultures. In 2015, scientists even edited human tripronuclear zygotes. These tools allow us to change the genetic instructions within living organisms. This technology connects the ancient survival strategies of bacteria to the future of human medicine and genetic engineering.